Skip to main content
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · IEX Real-Time Price · USD
4.360
-0.150 (-3.33%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $28.01M in the twelve months ending March 31, 2024, with 198.84% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.43M with 7.84% year-over-year growth. In the year 2023, Zevra Therapeutics had annual revenue of $27.46M with 170.26% growth.

Revenue (ttm)
$28.01M
Revenue Growth
+198.84%
P/S Ratio
6.52
Revenue / Employee
$430,877
Employees
65
Market Cap
182.48M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.46M17.30M170.26%
Dec 31, 202210.16M-18.49M-64.53%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 321.52M
Coherus BioSciences 301.87M
Outset Medical 125.08M
bluebird bio 21.73M
Shattuck Labs 2.72M
Sera Prognostics 206.00K
Revenue Rankings

ZVRA News

More News